Biotechnology/Biologics US-FDA
FDA Issues Draft Guidance on Regulating Genetically Engineered Animals
Public comment invited on application of new animal drug provisions of the Federal Food Drug and Cosmetic Act
Date:
09/18/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01887.html
Beware of drug names that look, sound alike
Celebrex or Celexa? 1,500 common meds have caused mix-ups, study says
Date:
09/01/2008
, Publication:
MSNBC
, Author:
LURAN NEERGAARD AP
http://www.msnbc.msn.com/id/26497545/
FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees
The improvements include stricter limits on financial conflicts of interest for committee members, ...
Date:
08/05/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01871.html
Little monitoring for 'off-label' drug marketing
Report: FDA doesn't track drug makers peddling meds for unapproved use
Date:
07/27/2008
, Publication:
MSNBC
, Author:
AP
http://www.msnbc.msn.com/id/25874072/
FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and EfficientDate:
07/19/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01863.html
FDA Revises Process for Responding to Drug Applications
The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
Date:
07/09/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html
Possible lymphoma link to TNF-blockers sparks agency review
...including adalimumab (Humira, Abbott), etanercept (Enbrel, Amgen/Wyeth), infliximab (Remicade, Centocor), and certolizumab pegol (Cimzia, UCB Inc.)for data on all cases of cancer reported in children and young adults...
Date:
06/06/2008
, Publication:
Drug Topics Daily News
, Author:
Heidi Belden, Pharm.D.
http://drugtopics.modernmedicine.com/drugtopics/Allergies/Possible-lymphoma-lin
F.D.A. Reviews Arthritis Drugs for Links to Cancer
...investigating whether four drugs used to treat rheumatoid arthritis and other immune system diseases might increase the risk of cancer in children.
Date:
06/05/2008
, Publication:
NY TIMES
, Author:
ANDREW POLLACK
http://www.nytimes.com/2008/06/05/business/05drug.html?ref=health
F.D.A. to Expand Scrutiny of Risks From Drugs After They're Approved for Sale
The new system, called the Sentinel Initiative, will allow officials from the Food and Drug Administration for the first time to monitor almost immediately how drugs affect health...
Date:
05/23/2008
, Publication:
NY TIMES
, Author:
GARDINER HARRIS
http://www.nytimes.com/2008/05/23/washington/23fda.html?ref=health
FDA to launch pilot on drug names and safety
FDA is holding a meeting, launching a pilot, and releasing a concept paper about drug names next month.
Date:
05/13/2008
, Publication:
Drug Topics Daily News
, Author:
Judy Chi
http://drugtopics.modernmedicine.com/drugtopics/Government+And+Law/FDA-to-launc
Previous
Page 1 of 23
Next >
Search returned 229 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|